A polymorphism in a conserved posttranscriptional regulatory motif alters bone morphogenetic protein 2 (BMP2) RNA:Protein interactions

Molecular Endocrinology

Volumn 20, Issue 7, 2006, Pages 1574-1586

  Fritz, David T ^a   Jiang, Shan ^a   Xu, Junwang ^a   Rogers, Melissa B ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; MESSENGER RNA;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE EXPRESSION; GENETIC TRANSCRIPTION; IN VITRO STUDY; MOUSE; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MOTIF; PROTEIN POLYMORPHISM; PROTEIN RNA BINDING; RNA DEGRADATION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION;

3' UNTRANSLATED REGIONS; ANIMALS; ANIMALS, NEWBORN; BONE AND BONES; BONE DEVELOPMENT; BONE MORPHOGENETIC PROTEINS; CONSERVED SEQUENCE; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; MICE; MICE, TRANSGENIC; ORGAN SPECIFICITY; OSTEOPOROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BINDING; RECEPTORS, ANDROGEN; REGULATORY ELEMENTS, TRANSCRIPTIONAL; RNA; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA STABILITY; TISSUE DISTRIBUTION; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; TRANSGENES; UP-REGULATION;

MAMMALIA; PISCES;

EID: 33745664520     PISSN: 08888809     EISSN: 08888809     Source Type: Journal    
DOI: 10.1210/me.2005-0469     Document Type: Article

References (113)

1. Reddi AH 2001 Bone morphogenetic proteins: from basic science to clinical applications. J Bone Joint Surg Am 83-A:S1-S6
2. Urist M 1965 Bone: formation by autoinduction. Science 150:893-899
3. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA. 1988 Novel regulators of bone formation: molecular clones and activities. Science 242:1528-1534
4. Hogan B 1996 Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 10:1580-1594
5. Vainio S, Karavanova I, Jowett A, Thesleff I 1993 Identification of BMP-4 as a signal mediating secondary induction between epithelial and mesenchymal tissues during early tooth development. Cell 75:45-58
6. Glozak MA, Rogers MB 1996 Specific induction of apoptosis in P19 embryonal carcinoma cells by retinoic acid and BMP2 or BMP4. Dev Biol 179:458-470
7. Graham A, Francis-West P, Brickell P, Lumsden A 1994 The signalling molecule BMP4 mediates apoptosis in the rhombencephalic neural crest. Nature 372:684-686
8. Vaahtokari A, Aberg T, Thesleff I 1996 Apoptosis in the developing tooth: association with an embryonic signaling center and suppression by EGF and FGF-4. Development 122:121-129
9. Zou H, Niswander L 1996 Requirement for BMP signaling in interdigital apoptosis and scale formation. Science 272:738-741
10. Graff J 1997 Embryonic patterning: to BMP or not to BMP, that is the question. Cell 89:171-174
11. Winnier G, Blessing M, Labosky PA, Hogan BL 1995 Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 9:2105-2116
12. Zhang H, Bradley A 1996 Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 122:2977-2986
13. Yi SE, Daluiski A, Pederson R, Rosen V, Lyons KM 2000 The type I BMP receptor BMPRIB is required for chondrogenesis in the mouse limb. Development 127:621-630
14. Mishina Y, Suzuki A, Ueno N, Behringer RR 1995 Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev 9:3027-3037
15. Beppu H, Kawabata M, Hamamoto T, Chytil A, Minowa O, Noda T, Miyazono K 2000 BMP type II receptor is required for gastrulation and early development of mouse embryos. Dev Biol 221:249-258
16. Baur ST, Mai JJ, Dymecki SM 2000 Combinatorial signaling through BMP receptor IB and GDF5: shaping of the distal mouse limb and the genetics of distal limb diversity. Development 127:605-619
17. Chang H, Huylebroeck D, Verschueren K, Guo Q, Matzuk MM, Zwijsen A 1999 Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects. Development 126:1631-1642
18. Sirard C, de la Pompa JL, Elia A, Itie A, Mirtsos C, Cheung A, Hahn S, Wakeham A, Schwartz L, Kern SE, Rossant J, Mak TW 1998 The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev 12:107-119
19. Tremblay KD, Dunn NR, Robertson EJ 2001 Mouse embryos lacking Smad1 signals display defects in extra-embryonic tissues and germ cell formation. Development 128:3609-3621
20. Yang X, Li C, Xu X, Deng C 1998 The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice. Proc Natl Acad Sci USA 95:3667-3672
21. Yang X, Castilla LH, Xu X, Li C, Gotay J, Weinstein M, Liu PP, Deng CX 1999 Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5. Development 126:1571-1580
22. Styrkarsdottir U, Cazier JB, Kong A, Rolfsson O, Larsen H, Bjarnadottir E, Johannsdottir VD, Sigurdardottir MS, Bagger Y, Christiansen C, Reynisdottir I, Grant SF, Jonasson K, Frigge ML, Gulcher JR, Sigurdsson G, Stefansson K 2003 Linkage of osteoporosis to chromosome 20p12 and association to BMP2. PLoS Biol 1:E69
23. Reneland RH, Mah S, Kammerer S, Hoyal CR, Marnellos G, Wilson SG, Sambrook PN, Spector TD, Nelson MR, Braun A 2005 Association between a variation in the phosphodiesterase 4D gene and bone mineral density. BMC Med Genet 6:9
24. Turgeman G, Zilberman Y, Zhou S, Kelly P, Moutsatsos IK, Kharode YP, Borella LE, Bex FJ, Komm BS, Bodine PV, Gazit D 2002 Systemically administered rhBMP-2 promotes MSC activity and reverses bone and cartilage loss in osteopenic mice. J Cell Biochem 86:461-474
25. Valdes AM, Hart DJ, Jones KA, Surdulescu G, Swarbrick P, Doyle DV, Schafer AJ, Spector TD 2004 Association study of candidate genes for the prevalence and progression of knee osteoarthritis. Arthritis Rheum 50:2497-2507
26. Marcelino J, Sciortino CM, Romero MF, Ulatowski LM, Ballock RT, Economides AN, Eimon PM, Harland RM, Warman ML 2001 Human disease-causing NOG missense mutations: effects on noggin secretion, dimer formation, and bone morphogenetic protein binding. Proc Natl Acad Sci USA 98:11353-11358
27. Gong Y, Krakow D, Marcelino J, Wilkin D, Chitayat D, Babul-Hirji R, Hudgins L, Cremers CW, Cremers FP, Brunner HG, Reinker K, Rimoin DL, Cohn DH, Goodman FR, Reardon W, Patton M, Francomano CA, Warman ML 1999 Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis. Nat Genet 21:302-304
28. Shafritz AB, Shore EM, Gannon FH, Zasloff MA, Taub R, Muenke M, Kaplan FS 1996 Overexpression of an osteogeneic morphogen in fibrodysplasia ossificans progressiva. N Engl J Med 335:555-561
29. Mishina Y, Starbuck MW, Gentile MA, Mishina Y, Starbuck MW, Gentile MA, Fukuda T, Kasparcova V, Seedor JG, Hanks MC, Amling M, Pinero GJ, Harada S, Behringer RR 2004 Bone morphogenetic protein type IA receptor signaling regulates postnatal osteoblast function and bone remodeling. J Biol Chem 279:27560-27566
30. Devlin RD, Du Z, Pereira RC, Kimble RB, Economides AN, Jorgetti V, Canalis E 2003 Skeletal overexpression of noggin results in osteopenia and reduced bone formation. Endocrinology 144:1972-1978
31. Wu XB, Li Y, Schneider A, Yu W, Rajendren G, Iqbal J, Yamamoto M, Alam M, Brunet LJ, Blair HC, Zaidi M, Abe E 2003 Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice. J Clin Invest 112:924-934
32. Zhao M, Harris SE, Horn D, Geng Z, Nishimura R, Mundy GR, Chen D 2002 Bone morphogenetic protein receptor signaling is necessary for normal murine postnatal bone formation. J Cell Biol 157:1049-1060
33. Chen D, Zhao M, Mundy GR 2004 Bone morphogenetic proteins. Growth Factors 22:233-241
34. Usui M, Yoshida Y, Tsuji K, Oikawa K, Miyazono K, Ishikawa I, Yamamoto T, Nifuji A, Noda M 2004 Tob deficiency superenhances osteoblastic activity after ovariectomy to block estrogen deficiency-induced osteoporosis. Proc Natl Acad Sci USA 101:6653-6658
35. Fritz DT, Liu D, Xu J, Jiang S, Rogers MB 2004 Conservation of Bmp2 post-transcriptional regulatory mechanisms. J Biol Chem 279:48950-48958
36. Heller LC, Li Y, Abrams KA, Rogers MB 1999 Transcriptional regulation of the Bmp2 gene: retinoic acid induction in F9 embryonal carcinoma cells and Saccharomyces cerevisiae. J Biol Chem 274:1394-1400
37. Abrams KL, Xu J, Nativelle-Serpentini C, Dabirshahsahebi S, Rogers MB 2004 An evolutionary and molecular analysis of Bmp2 expression. J Biol Chem 279:15916-15928
38. Feng J, Harris M, Ghosh-Choudhury N, Feng M, Mundy G, Harris S 1994 Structure and sequence of mouse bone morphogenetic protein-2 gene (BMP-2): comparison of the structures and promoter regions of BMP2- and BMP-4 genes. Biochim Biophys Acta 1218:221-224
39. Feng JQ, Chen D, Ghosh-Choudhury N, Esparza J, Mundy GR, Harris SE 1997 Bone morphogenetic protein 2 transcripts in rapidly developing deer antler tissue contain an extended 5′ non-coding region arising from a distal promoter. Biochim Biophys Acta 1350:47-52
40. Helvering LM, Sharp RL, Ou X, Geiser AG 2000 Regulation of the promoters for the human bone morphogenetic protein 2 and 4 genes. Gene 256:123-138
41. Ghosh-Choudhury N, Abboud SL, Mahimainathan L, Chandrasekar B, Choudhury GG 2003 Phosphatidylinositol 3-kinase regulates bone morphogenetic protein-2 (BMP-2)-induced myocyte enhancer factor 2A-dependent transcription of BMP-2 gene in cardiomyocyte precursor cells. J Biol Chem 278:21998-22005
42. Ghosh-Choudhury N, Choudhury GG, Harris MA, Wozney J, Mundy GR, Abboud SL, Harris SE 2001 Autoregulation of mouse BMP-2 gene transcription is directed by the proximal promoter element. Biochem Biophys Res Commun 286:101-108
43. Canalis E, Economides AN, Gazzerro E 2003 Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev 24:218-235
44. Miyazono K 2000 Positive and negative regulation of TGF-β signaling. J Cell Sci 113:1101-1109
45. Merino R, Rodriguez-Leon J, Macias D, Ganan Y, Economides AN, Hurle JM 1999 The BMP antagonist gremlin regulates outgrowth, chondrogenesis and programmed cell death in the developing limb. Development 126:5515-5522
46. Kakoki M, Tsai YS, Kim HS, Hatada S, Ciavatta DJ, Takahashi N, Arnold LW, Maeda N, Smithies O 2004 Altering the expression in mice of genes by modifying their 3′ regions. Dev Cell 6:597-606
47. Dermitzakis ET, Kirkness E, Schwarz S, Birney E, Reymond A, Antonarakis SE 2004 Comparison of human chromosome 21 conserved nongenic sequences (CNGs) with the mouse and dog genomes shows that their selective constraint is independent of their genic environment. Genome Res 14:852-859
48. Dermitzakis ET, Reymond A, Lyle R, Scamuffa N, Ucla C, Deutsch S, Stevenson BJ, Flegel V, Bucher P, Jongeneel CV, Antonarakis SE 2002 Numerous potentially functional but non-genic conserved sequences on human chromosome 21. Nature 420:578-582
49. Strickland S, Mahdavi V 1978 The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 15:393-403
50. Strickland S, Smith KK, Marotti KR 1980 Hormonal induction of differentiation in teratocarcinoma stem cells: generation of parietal endoderm by retinoic acid and dibutyryl cAMP. Cell 21:347-355
51. Rogers MB, Rosen V, Wozney JM, Gudas LJ 1992 Bone morphogenetic proteins-2 and 4 are involved in the retinoic acid-induced differentiation of embryonal carcinoma cells. Mol Biol Cell 3:189-196
52. Rogers M 1996 Receptor-selective retinoids implicate RAR α and γ in the regulation of bmp-2 and bmp-4 in F9 embryonal carcinoma cells. Cell Growth Differ 7:115-122
53. Hogan B, Beddington R, Constantini F, Lacy E 1994 Manipulating the mouse embryo, a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory
54. Lyons K, Pelton R, Hogan B 1989 Patterns of expression of murine Vgr-1 and BMP-2a RNA suggest that transforming growth factor-β-like genes coordinately regulate aspects of embryonic development. Genes Dev 3:1657-1668
55. Lyons KM, Pelton RW, Hogan BLM 1990 Organogenesis and pattern formation in the mouse: RNA distribution patterns suggest a role for Bone Morphogenetic Protein-2A (BMP-2A). Development 109:833-844
56. Jones CM, Lyons KM, Hogan BLM 1991 Involvement of Bone Morphogenetic Protein-4 (BMP-4) and Vgr-1 in morphogenesis and neurogenesis in the mouse. Development 111:531-542
57. Bitgood MJ, McMahon AP 1995 Hedgehog and Bmp genes are coexpressed at many diverse sites of cell-cell interaction in the mouse embryo. Dev Biol 172:126-138
58. Furuta Y, Piston DW, Hogan BL 1997 Bone morphogenetic proteins (BMPs) as regulators of dorsal forebrain development. Development 124:2203-2212
59. Dudley AT, Robertson EJ 1997 Overlapping expression domains of bone morphogenetic protein family members potentially account for limited tissue defects in BMP7 deficient embryos. Dev Dyn 208:349-362
60. Jin Y, Lu HB, Liong E, Lau TY, Tipoe GL 2001 Transcriptional mRNA of BMP-2, 3, 4, and 5 in trigeminal nerve, benign and malignant peripheral nerve sheath tumors. Histol Histopathol 16:1013-1019
61. Belecky-Adams T, Adler R 2001 Developmental expression patterns of bone morphogenetic proteins, receptors, and binding proteins in the chick retina. J Comp Neurol 430:562-572
62. Feng JQ, Xing L, Zhang JH, Zhao M, Horn D, Chan J, Boyce BF, Harris SE, Mundy GR, Chen D 2003 NF-κB specifically activates BMP-2 gene expression in growth plate chondrocytes in vivo and in a chondrocyte cell line in vitro. J Biol Chem 278:29130-29135
63. Wilusz CJ, Wormington M, Peltz SW 2001 The cap-totail guide to mRNA turnover. Nat Rev Mol Cell Biol 2:237-246
64. Wilusz CJ, Wilusz J 2004 Bringing the role of mRNA decay in the control of gene expression into focus. Trends Genet 20:491-497
65. Bakheet T, Williams BR, Khabar KS 2003 ARED 2.0: an update of AU-rich element mRNA database. Nucleic Acids Res 31:421-423
66. Khabar KS, Dhalla M, Al-Haj L, Bakheet T, Sy C, Naemmuddin M 2004 Selection of AU-rich transiently expressed sequences: reversal of cDNA abundance. RNA 10:747-753
67. Fritz DT, Ford LP, Wilusz J 2000 An in vitro assay to study regulated mRNA stability. Sci STKE 2000:PL1
68. Mukherjee D, Fritz DT, Kilpatrick WJ, Gao M, Wilusz J 2004 Analysis of RNA exonucleolytic activities in cellular extracts. Methods Mol Biol 257:193-212
69. Fritz DT, Bergman N, Kilpatrick WJ, Wilusz CJ, Wilusz J 2004 Messenger RNA decay in mammalian cells: the exonuclease perspective. Cell Biochem Biophys 41:265-278
70. Ford LP, Wilusz J 1999 An in vitro system using HeLa cytoplasmic extracts that reproduces regulated mRNA stability. Methods 17:21-27
71. Ford LP, Watson J, Keene JD, Wilusz J 1999 ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system. Genes Dev 13:188-201
72. Laroia G, Cuesta R, Brewer G, Schneider RJ 1999 Control of mRNA decay by heat shock-ubiquitin-proteasome pathway. Science 284:499-502
73. Sarkar B, Xi Q, He C, Schneider RJ 2003 Selective degradation of AU-rich mRNAs promoted by the p37 AUF1 protein isoform. Mol Cell Biol 23:6685-6693
74. Wagner BJ, DeMaria CT, Sun Y, Wilson GM, Brewer G 1998 Structure and genomic organization of the human AUF1 gene: alternative pre-mRNA splicing generates four protein isoforms. Genomics 48:195-202
75. Raineri I, Wegmueller D, Gross B, Certa U, Moroni C 2004 Roles of AUF1 isoforms, HuR and BRF1 in ARE-dependent mRNA turnover studied by RNA interference. Nucleic Acids Res 32:1279-1288
76. Lai WS, Carballo E, Strum JR, Kennington EA, Phillips RS, Blackshear PJ 1999 Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor α mRNA. Mol Cell Biol 19:4311-4323
77. Blackshear PJ 2002 Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover. Biochem Soc Trans 30:945-952
78. Carballo E, Lai WS, Blackshear PJ 1998 Feedback inhibition of macrophage tumor necrosis factor-α production by tristetraprolin. Science 281:1001-1005
79. Mukherjee D, Gao M, O'Connor JP, Raijmakers R, Pruijn G, Lutz CS, Wilusz J 2002 The mammalian exosome mediates the efficient degradation of mRNAs that contain AU-rich elements. EMBO J 21:165-174
80. Lutz CS, Alwine JC 1994 Direct interaction of the U1 snRNP-A protein with the upstream efficiency element of the SV40 late polyadenylation signal. Genes Dev 8:576-586
81. Adams DJ, Beveridge DJ, van der Weyden L, Mangs H, Leedman PJ, Morris BJ 2003 HADHB, HuR, and CP1 bind to the distal 3′-untranslated region of human renin mRNA and differentially modulate renin expression. J Biol Chem 278:44894-44903
82. Tran H, Maurer F, Nagamine Y 2003 Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2. Mol Cell Biol 23:7177-7188
83. Tran H, Schilling M, Wirbelauer C, Hess D, Nagamine Y 2004 Facilitation of mRNA deadenylation and decay by the exosome-bound, DExH protein RHAU. Mol Cell 13:101-111
84. Raghavan A, Robison RL, McNabb J, Miller CR, Williams DA, Bohjanen PR 2001 HuA and tristetraprolin are induced following T cell activation and display distinct but overlapping RNA binding specificities. J Biol Chem 276:47958-47965
85. Lal A, Mazan-Mamczarz K, Kawai T, Yang X, Martindale JL, Gorospe M 2004 Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs. EMBO J 23:3092-3102
86. Linker K, Pautz A, Fechir M, Hubrich T, Greeve J, Kleinert H 2005 Involvement of KSRP in the post-transcriptional regulation of human iNOS expression-complex interplay of KSRP with TTP and HuR. Nucleic Acids Res 33:4813-4827
87. Ralston SH 2003 Genetic determinants of susceptibility to osteoporosis. Curr Opin Pharmacol 3:286-290
88. Ralston SH 2002 Genetic control of susceptibility to osteoporosis. J Clin Endocrinol Metab 87:2460-2466
89. Fan XC, Steitz JA 1998 Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J 17:3448-3460
90. Keene JD 1999 Why is Hu where? Shuttling of earlyresponse-gene messenger RNA subsets. Proc Natl Acad Sci USA 96:5-7
91. Keene JD 2001 Ribonucleoprotein infrastructure regulating the flow of genetic information between the genome and the proteome. Proc Natl Acad Sci USA 98:7018-7024
92. Peng SS, Chen CY, Xu N, Shyu AB 1998 RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J 17:3461-3470
93. van der Giessen K, Di-Marco S, Clair E, Gallouzi IE 2003 RNAi-mediated HuR depletion leads to the inhibition of muscle cell differentiation. J Biol Chem 278:47119-47128
94. McMullen MR, Cocuzzi E, Hatzoglou M, Nagy LE 2003 Chronic ethanol exposure increases the binding of HuR to the TNFα 3′-untranslated region in macrophages. J Biol Chem 278:38333-38341
95. Loflin P, Chen CY, Shyu AB 1999 Unraveling a cytoplasmic role for hnRNP D in the in vivo mRNA destabilization directed by the AU-rich element. Genes Dev 13:1884-1897
96. Fukui N, Zhu Y, Maloney WJ, Clohisy J, Sandell LJ 2003 Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-α in normal and osteoarthritic chondrocytes. J Bone Joint Surg Am 85-A(Suppl 3):59-66
97. Lories RJ, Derese I, Ceuppens JL, Luyten FP 2003 Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis. Arthritis Rheum 48:2807-2818
98. Langenfeld EM, Calvano SE, Abou-Nukta F, Lowry SF, Amenta P, Langenfeld J 2003 The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells. Carcinogenesis 24:1445-1454
99. Horvath LG, Henshall SM, Kench JG, Turner JJ, Golovsky D, Brenner PC, O'Neill GF, Kooner R, Stricker PD, Grygiel JJ, Sutherland RL 2004 Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression. Prostate 59:234-242
100. Kleeff J, Maruyama H, Ishiwata T, Sawhney H, Friess H, Buchler MW, Korc M 1999 Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo. Gastroenterology 116:1202-1216
101. Hardwick JC, Van Den Brink GR, Bleuming SA, Ballester I, Van Den Brande JM, Keller JJ, Offerhaus GJ, Van Deventer SJ, Peppelenbosch MP 2004 Bone morphogenetic protein 2 is expressed by, and acts upon, mature epithelial cells in the colon. Gastroenterology 126:111-121
102. Reinholz MM, Iturria SJ, Ingle JN, Roche PC 2002 Differential gene expression of TGF-β family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR. Breast Cancer Res Treat 74:255-269
103. Harris SE, Harris MA, Mahy P, Wozney J, Feng JQ, Mundy GR 1994 Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells. Prostate 24:204-211
104. Coucouvanis E, Martin GR 1999 BMP signaling plays a role in visceral endoderm differentiation and cavitation in the early mouse embryo. Development 126:535-546
105. Rodriguez-Leon J, Merino R, Macias D, Ganan Y, Santesteban E, Hurle JM 1999 Retinoic acid regulates programmed cell death through BMP signalling. Nat Cell Biol 1:125-126
106. Zhang S, Fantozzi I, Tigno DD, Yi ES, Platoshyn O, Thistlethwaite PA, Kriett JM, Yung G, Rubin LJ, Yuan JX 2003 Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells. Am J Physiol 285:L740-L754
107. Hallahan AR, Pritchard JI, Chandraratna RA, Ellenbogen RG, Geyer JR, Overland RP, Strand AD, Tapscott SJ, Olson JM 2003 BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect. Nat Med 9:1033-1038
108. Kawamura C, Kizaki M, Yamato K, Uchida H, Fukuchi Y, Hattori Y, Koseki T, Nishihara T, Ikeda Y 2000 Bone morphogenetic protein-2 induces apoptosis in human myeloma cells with modulation of STAT3. Blood 96:2005-2011
109. Baron U, Freundlieb S, Gossen M, Bujard H 1995 Coregulation of two gene activities by tetracycline via a bidirectional promoter. Nucleic Acids Res 23:3605-3606
110. Agah R, Frenkel PA, French BA, Michael LH, Overbeek PA, Schneider MD 1997 Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J Clin Invest 100:169-179
111. Vasios GW, Gold JD, Petkovich M, Chambon P, Gudas LJ 1989 A retinoic acid-responsive element is present in the 5′ flanking region of the laminin B1 gene. Proc Natl Acad Sci USA 86:9099-9103
112. Natalizio BJ, Muniz LC, Arhin GK, Wilusz J, Lutz CS 2002 Upstream elements present in the 3′-untranslated region of collagen genes influence the processing efficiency of overlapping polyadenylation signals. J Biol Chem 277:42733-42740
113. Wilusz J, Shenk T 1988 A 64 kd nuclear protein binds to RNA segments that include the AAUAAA polyadenylation motif. Cell 52:221-228